Rare diseases
Investigational molecules
Locations
364 conditions with trials, the busiest first
1 206 trials across Europe, recruiting first
Study on Povetacicept for Patients with Autoimmune Cytopenias (wAIHA, CAD, ITP)
AustriaStudy on Zanubrutinib for Patients with Primary Cold Agglutinin Disease
BelgiumStudy on Alnuctamab and Drug Combination for Patients with Relapsed or Refractory Multiple Myeloma
AustriaStudy on Tafasitamab and Lenalidomide with Standard Therapy for Newly Diagnosed High-Risk Diffuse Large B-Cell Lymphoma Patients
AustriaStudy Comparing Rituximab and Zanubrutinib with Rituximab Alone for Untreated Patients with Splenic Marginal Zone Lymphoma
AustriaStudy on Acalabrutinib for Very Old or Frail Patients with Chronic Lymphocytic Leukemia
AustriaStudy of Mosunetuzumab and Drug Combination for Untreated Patients with Richter's Syndrome
SpainStudy on Epcoritamab, Rituximab, and Lenalidomide for Adults with Untreated Follicular Lymphoma
BelgiumStudy on Mosunetuzumab and Lenalidomide for Patients with Untreated Follicular Lymphoma
AustriaStudy of Mogamulizumab and Total Skin Electron Beam Therapy for Patients with Stage IB-IIB Cutaneous T-Cell Lymphoma
DenmarkStudy of Lacutamab Alone or with Chemotherapy for Patients with Advanced T-Cell Lymphoma
BelgiumStudy on Isatuximab, Carfilzomib, and Dexamethasone for Adults with Relapsed or Refractory Multiple Myeloma
CzechiaThe therapies tested most often in Blood and lymphatic system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
